 Clinical Oncology News | In Follicular Lymphoma, Rituximab 'Retreatment' Better Than ... Clinical Oncology News San Diego—In previously untreated patients with low tumor burden (LTB) follicular lymphoma (FL), new Phase III data suggests that maintenance rituximab is ... |
